[Form 4] Arcosa, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Cole Kerry S. Cole, Group President of Arcosa, Inc. (ACA) reported a sale of common stock on 08/11/2025. The Form 4 shows a disposition of 7,966 shares at a price of $95.77 and a post-transaction direct ownership of 19,769 shares. The filing documents an insider sale while confirming continued meaningful direct ownership by the reporting officer.

Positive

• Transparent disclosure of the insider sale via a Form 4
• Post-transaction direct ownership remains 19,769 shares, indicating continued insider stake

Negative

• Insider disposed of 7,966 shares at $95.77
• Reduction in holdings from the pre-transaction amount to 19,769 shares direct ownership

Insights

Financial Analyst

TL;DR: Insider sale of 7,966 ACA shares at $95.77; post-sale ownership remains 19,769 shares, a neutral disclosure for investors.

The Form 4 shows a single, non-derivative sale by Group President Cole Kerry S. The transaction is explicit: 7,966 shares were disposed at $95.77, leaving 19,769 shares directly owned. This is a straightforward liquidity event recorded under Section 16 reporting and does not by itself indicate a material change to company operations or capitalization.

Corporate Governance Expert

TL;DR: Timely Section 16 disclosure of an officer sale, maintaining transparency with substantial remaining direct holdings.

The filing documents the required insider disclosure for an officer-level transaction. It confirms the officer continues to hold a significant number of shares after the sale, preserving alignment with shareholders. The Form 4 is signed by a power of attorney, which is a common administrative practice for such filings.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Cole Kerry S

(Last) (First) (Middle)

500 NORTH AKARD ST., SUITE 400

(Street)

DALLAS TX 75201

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Arcosa, Inc. [ ACA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group President

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2025		S		7,966	D	$95.77	19,769	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ Mark Elmore, by Power of Attorney	08/11/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Arcosa (ACA) reporting person make?

The reporting person sold 7,966 shares of Arcosa common stock on 08/11/2025 at a price of $95.77 per share.

How many Arcosa (ACA) shares does the reporting person own after the transaction?

After the reported sale the reporting person directly owns 19,769 shares of Arcosa common stock.

What is the reporting person's role at Arcosa (ACA)?

The Form 4 identifies the reporting person as Group President and an officer of Arcosa, Inc.

Was the transaction reported on a Form 4 for Arcosa (ACA)?

Yes. The sale was disclosed on a SEC Form 4 reporting changes in beneficial ownership under Section 16.

Who signed the Form 4 for the Arcosa (ACA) reporting person?

The Form 4 bears a signature executed by Mark Elmore, by Power of Attorney on 08/11/2025.